TokenPost·
Health Canada Approves Lilly’s Mounjaro for Cardiovascular Risk Reduction

The indication applies to adults with type 2 diabetes and established cardiovascular disease, with the decision based on SURPASS-CVOT trial results.
Every crypto headline. One feed. Updated every minute.

The indication applies to adults with type 2 diabetes and established cardiovascular disease, with the decision based on SURPASS-CVOT trial results.